In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
 Stefanie Schuepke
Speaker
Stefanie Schuepke
Stefanie Schuepke Stefanie Schuepke

German Heart Center, Munich (Germany)

Specialities : Acute Coronary Syndromes , Coronary Artery Disease Chronic, Interventional Cardiology

8 presentations from this speaker

Antithrombotic strategies in coronary interventions.

Event : ESC Congress 2019

  • Session : Percutaneous interventions: Essential Update
  • Speaker : S Schuepke (Munich,DE)

ISAR-REACT 5

Event : ESC Congress 2019

  • Session : Meet the trialist - ISAR-REACT 5
  • Speaker : S Schuepke (Munich,DE)

De-escalation of dual antiplatelet therapy intensity in acute coronary syndrome.

Event : ESC Congress 2018

  • Session : Safer stents and strategies: is it time for the de-escalation of dual antiplatelet treatment regimes?
  • Speaker : S Schuepke (Munich,DE)

P2Y12 inhibitors in NSTE-ACS - Best administered in the cath lab!

Event : ESC Congress 2018

  • Session : Dual antiplatelet therapy and PCI - Important controversies
  • Speaker : S Schuepke (Munich,DE)

P2Y12 inhibitors in NSTE-ACS - Best administered in the cath lab! Rebuttal

Event : ESC Congress 2018

  • Session : Dual antiplatelet therapy and PCI - Important controversies
  • Speaker : S Schuepke (Munich,DE)

ISAR-SAFE: when to stop dual antiplatelet therapy after ACS?

Event : ESC Congress 2015

  • Session : Treatment of coronary artery disease: from recent clinical trials to practice
  • Speaker : S Schuepke (Munich,DE)

Duration of dual antiplatelet therapy?

Event : ESC Congress 2014

  • Session : New insights in stent thrombosis
  • Speaker : S Schuepke (Munich,DE)

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are